Sakar Healthcare Peer Comparison

NSE: SAKAR

₹1,093.05

₹-28.80 (-2.57%)

As on 30-Sep-2026IST

Market cap

₹2,432 Cr

Revenue (TTM)

₹272 Cr

P/E Ratio

67.4

P/B Ratio

7.3

Div. Yield

0 %

Edit

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	2,432	20,590	20,453	17,730	16,511
Revenue (₹ Cr)	272	2,287	1,682	2,570	3,230
Net Profit (₹ Cr)	36.10	678.07	273.51	735.15	666.92
Net Margin (%)	13.11	28.10	16.19	26.88	20.60
RoE (%)	11.50	19.73	11.15	19.16	18.75
Price to Earnings	67.37	30.95	68.79	24.12	25.64
Price-To-Book	7.27	5.61	7.61	4.02	4.09

Income Statement (₹ Cr)

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Operating Revenue	271.97	2,287.33	1,682.47	2,569.77	3,229.67
Total Income	275.41	2,413.29	1,689.83	2,735.39	3,237.12
Total Expenditure	194.54	1,490.75	1,203.91	1,628.14	2,090.06
EBITDA	77.43	796.58	478.55	941.63	1,139.61
Depreciation	24.54	78.10	126.01	57.58	281.06
EBIT	52.90	718.48	352.55	884.05	858.55
Interest	7.38	0.88	52.11	7.69	190.64
Other Income	3.44	125.96	7.37	165.62	7.45
Exceptional Items	0.00	0.00	12.16	-49.16	-17.24
Profit before Tax	48.95	843.56	319.96	992.82	658.12
Provision for Tax	12.85	165.49	46.45	257.67	-8.80
Profit after Tax	36.10	678.07	273.51	735.15	666.92

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Shareholder's Funds	324.45	3,586.42	2,591.20	4,202.90	3,902.67
Minority Interest	0.00	-12.71	0.00	0.00	-21.81
Non-Current Liabilities	47.02	28.74	266.35	91.50	1,392.75
Current Liabilities	109.54	385.94	848.06	627.48	2,077.10
Total Liabilities	415.26	3,207.85	3,310.68	4,911.11	6,865.52

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Non-Current Assets	330.75	1,291.22	2,525.44	770.28	5,617.77
Current Assets	140.46	2,585.66	1,109.77	3,803.22	1,539.85
Total Assets	415.26	3,207.85	3,310.68	4,911.11	6,865.52
Total Debt*	86.37	0.55	586.37	2.50	2,421.66
Net Current Assets	30.92	2,199.72	261.71	3,175.74	-537.25
Contingent Liabilities	--	0.64	76.22	363.79	51.96

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Cash From Operating Activities	34.03	432.37	132.27	659.75	1,065.01
Cash Flow from Investing Activities	-30.71	-334.73	-199.13	-71.34	-79.97
Cash from Financing Activities	-3.48	-38.32	62.65	-205.34	-881.32
Net Cash Inflow / Outflow	-0.16	59.32	-4.21	383.07	103.72

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
ROCE (%)	8.43	26.22	6.95	26.21	13.59
ROE (%)	11.50	19.73	11.15	19.16	18.75
ROA (%)	8.06	18.69	7.80	14.95	9.26
EBIT Margin (%)	19.45	31.41	20.95	34.40	26.58
Net Margin (%)	13.11	28.10	16.19	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Revenue Growth (%)	43.77	15.01	27.91	10.69	9.59
EBIT Growth (%)	74.62	18.45	58.32	24.14	16.84
Net Profit Growth (%)	82.69	19.61	149.56	-9.09	62.68
EPS Growth (%)	80.01	17.73	-3.57	14.40	67.41
Book Value Growth (%)	9.73	23.77	30.63	17.30	10.19

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Price / Earnings	67.37	30.95	72.97	22.98	24.99
Price / Book Value	7.27	5.61	7.61	4.02	4.09
Dividend Yield (%)	0.00	0.30	0.06	1.94	0.00
EV/EBITDA	32.52	24.58	44.02	15.53	16.46
Market Cap (₹ Cr)	464.72	15,219.80	6,484.12	18,318.10	19,292.77

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debt to Equity	0.10	0.00	0.07	0.00	0.24
Short term debt to equity ratio	0.07	0.00	0.13	0.00	0.14
Current Ratio	1.28	6.70	1.31	6.06	0.74
Quick Ratio	0.64	5.59	0.88	5.31	0.53
Interest Coverage	7.63	959.59	7.14	130.11	4.45

	Sakar Healthcare	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debtors to sales (%)	18.41	36.10	30.84	7.07	21.07
Asset Turnover	0.61	0.63	0.48	0.52	0.45
Receivable days	53.06	110.70	118.15	29.10	54.06
Inventory Days	73.30	65.86	98.29	69.53	32.16
Payable days	107.64	105.88	128.16	76.77	140.91
Cash Conversion Cycle	18.72	70.68	88.28	21.86	-54.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.